These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31567433)

  • 1. The controversial role of red cell transfusions for sickle cell pain.
    Karafin MS; Field JJ
    Curr Opin Hematol; 2019 Nov; 26(6):442-447. PubMed ID: 31567433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for red cell transfusion in sickle cell disease.
    Ohene-Frempong K
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):5-13. PubMed ID: 11206961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Patients with Sickle Cell Disease Using Transfusion Therapy: Guidelines and Complications.
    Chou ST; Fasano RM
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):591-608. PubMed ID: 27112998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How I manage red cell transfusions in patients with sickle cell disease.
    Rees DC; Robinson S; Howard J
    Br J Haematol; 2018 Feb; 180(4):607-617. PubMed ID: 29377071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crises in Sickle Cell Disease.
    Novelli EM; Gladwin MT
    Chest; 2016 Apr; 149(4):1082-93. PubMed ID: 26836899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for transfusion in the management of sickle cell disease.
    Han H; Hensch L; Tubman VN
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):696-703. PubMed ID: 34889416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease.
    Jeon WJ; Joung B; Moon JH; Hino C; Park D; Pham B; Castillo DR; Chong E; Kaur S; Grismore C; Cao H
    Hematology; 2023 Dec; 28(1):2215575. PubMed ID: 37227254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating anemia.
    King KE; Ness PM
    Hematol Oncol Clin North Am; 1996 Dec; 10(6):1305-20. PubMed ID: 8956018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Hulbert ML; Panepinto JA; Scott JP; Liem RI; Cook LJ; Simmons T; Brousseau DC;
    Transfusion; 2017 Aug; 57(8):1891-1897. PubMed ID: 28500682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management.
    Darbari DS; Sheehan VA; Ballas SK
    Eur J Haematol; 2020 Sep; 105(3):237-246. PubMed ID: 32301178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications and complications of transfusions in sickle cell disease.
    Smith-Whitley K; Thompson AA
    Pediatr Blood Cancer; 2012 Aug; 59(2):358-64. PubMed ID: 22566388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of red blood cell exchange for treating acute complications of sickle cell disease.
    Kozanoglu I; Ozdogu H
    Transfus Apher Sci; 2018 Feb; 57(1):23-26. PubMed ID: 29525569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues in blood transfusion for sickle cell disease.
    Wahl S; Quirolo KC
    Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Options for Sickle Cell Disease.
    Meier ER
    Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease; a general overview.
    Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
    Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the use of red blood cell exchange in sickle cell disease.
    Fort R
    Transfus Apher Sci; 2019 Apr; 58(2):128-131. PubMed ID: 30879904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.